// Biotech and Pharma Therapeutics With narcolepsy trial win, Axsome looks to revive former Pfizer antidepressant on the US market November 27, 2024 / Axsome Therapeutics AXS-12 / Narcolepsy Cataplexy Treatment / FDA Approval ProcessAxsome Therapeutics’ AXS-12 showed significant efficacy...

// Biotech and Pharma Therapeutics Nationwide IV fluid shortage changing how hospitals manage patient hydration November 19, 2024 / IV Fluid Shortage / Hospital Hydration Strategies / Hurricane Helene / Patient Care InnovationsA nationwide IV fluid shortage caused by Hurricane...